one hundred and two patients with neutropenia ( less than 1 x 10 ( 9 ) /l ) secondary to primary hematological disorders or chemotherapy for hematological malignancies were prospectively randomised , upon the development of fever or other signs of infection , to receive empirical antibiotic treatment with either ceftazidime ( +/- flucloxacillin ) ( n = 52 ) or azlocillin plus amikacin ( +/- flucloxacillin ) ( a & a , n = 50 ) .
C0015967
fever
C0007559
ceftazidime